Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers are Not Associated with Severe COVID-19 Infection in a Multi-Site UK Acute Hospital Trust

There was no evidence for increased severity of COVID-19 in hospitalised patients on chronic treatment with ACEi or ARB. A trend towards a beneficial effect of ACEi/ARB requires further evaluation in larger meta-analyses and randomised clinical trials.